V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007257 | 250005110 | 0 | 63.8 | Disease modification (D) | 2014-02-03 | 2014-02-03 | Chlorambucil | 2 | Y | 250031643 | RITUXIMAB |
| 250007258 | 250005111 | null | 76 | Palliative (P) | 2013-05-14 | 2013-05-21 | RUXOLITINIB | N | N | 250031644 | RUXOLITINIB |
| 250007259 | 250005111 | 1.47 | 89 | Palliative (P) | null | 2015-04-15 | ANAGRELIDE | 2 | Y | 250031644 | PEG INTERFERON |
| 250007260 | 250005112 | null | 82.4 | Disease modification (D) | 2013-12-04 | 2013-12-27 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 2 | N | 250031646 | TRIAL |
| 250007261 | 250005112 | 1.69 | 125 | Disease modification (D) | 2015-09-28 | 2015-10-20 | CHLORAMBUCIL + RITUXIMAB | N | N | 250031646 | TRIAL |
| 250007262 | 250005113 | 1.68 | 60 | Disease modification (D) | 2014-06-27 | 2014-06-27 | GEMCARBO | 02 | N | 250031653 | CVP R |
| 250007263 | 250005114 | null | 70 | Palliative (P) | 2017-02-13 | 2017-02-13 | Rituximab | 2 | N | 250031655 | RUXOLITINIB |
| 250007264 | 250005115 | null | null | Palliative (P) | 2016-08-22 | 2016-08-22 | CVP R | N | null | 250031656 | ATG + BUSULFAN + FLUDARABINE |
| 250007265 | 250005115 | 1.72 | null | Disease modification (D) | 2015-01-13 | 2015-01-26 | ANAGRELIDE | N | N | 250031656 | RITUXIMAB |
| 250007266 | 250005115 | 1.55 | 62 | Disease modification (D) | 2017-07-14 | 2017-07-21 | RUXOLITINIB | N | N | 250031656 | PILOT TRIAL |
| 250007268 | 250005117 | 0 | 0 | Palliative (P) | 2016-11-24 | 2016-12-08 | BUSULFAN | N | N | 250031664 | RUXOLITINIB |
| 250007269 | 250005117 | null | 44.45 | Palliative (P) | 2013-09-14 | 2013-09-14 | RUXOLITINIB | null | N | 250031664 | RUXOLITINIB |
| 250007270 | 250011599 | 1.53 | 81.8 | Disease modification (D) | 2015-08-18 | 2015-09-01 | ANAGRELIDE | 2 | N | 250031667 | RITUXIMAB |
| 250007271 | 250005118 | 0 | 86.4 | Palliative (P) | 2018-07-23 | 2018-08-05 | RUXOLITINIB | N | N | 250031668 | RUXOLITINIB |
| 250007272 | 250005118 | 1.57 | 98.9 | Curative (C) | 2018-06-01 | 2018-06-26 | RUXOLITINIB | N | N | 250031668 | INTERFERON |
| 250007273 | 250005119 | 1.55 | null | Not known (9) | 2016-02-17 | 2016-03-09 | RUXOLITINIB | N | N | 250031670 | IMATINIB |
| 250007274 | 250009704 | 1.55 | 0 | Palliative (P) | 2015-06-23 | 2015-06-30 | Cisplatin | 02 | N | 250031675 | CARBOPLATIN + PACLITAXEL |
| 250007275 | 250009704 | 1.68 | 0 | Disease modification (D) | 2016-01-29 | 2016-01-30 | R GCVP | N | N | 250031675 | DOXORUBICIN EMBOLISATION |
| 250007277 | 250005121 | 1.57 | 65.5 | Palliative (P) | 2014-09-19 | 2014-09-19 | RUXOLITINIB | 02 | N | 250031685 | RUXOLITINIB |
| 250007278 | 250005122 | null | null | Adjuvant (A) | 2017-03-17 | 2017-03-17 | RUXOLITINIB | N | N | 250031688 | RUXOLITINIB |
| 250007279 | 250005123 | 1.82 | 71.6 | Disease modification (D) | 2014-09-22 | 2014-10-13 | Cisplatin | N | N | 250031689 | GEMCARBO |
| 250007280 | 250005123 | 1.67 | 77.3 | Palliative (P) | 2015-06-15 | 2015-06-15 | ANAGRELIDE | 02 | N | 250031689 | RUXOLITINIB |
| 250007281 | 250005124 | 1.74 | 0 | Palliative (P) | 2016-11-13 | 2016-12-11 | RUXOLITINIB | null | N | 250031694 | BUSULPHAN |
| 250007282 | 250005125 | 1.71 | 106 | Adjuvant (A) | 2017-10-24 | 2017-10-25 | BUSULFAN | N | null | 250031696 | RUXOLITINIB |
| 250007283 | 250005126 | null | null | Disease modification (D) | 2015-09-26 | 2015-09-27 | RUXOLITINIB | 2 | N | 250031697 | AZACITIDINE |
| 250007284 | 250005127 | 0 | 90.4 | Palliative (P) | 2016-04-11 | 2016-04-11 | RUXOLITINIB | N | N | 250031699 | CHOP R |
| 250007285 | 250005128 | 1.8 | 88.4 | null | 2014-04-25 | 2014-04-25 | BUSULFAN | N | N | 250031702 | RUXOLITINIB |
| 250007286 | 250005129 | 1.62 | 75.4 | Neo-adjuvant (N) | 2013-10-17 | 2013-10-17 | RUXOLITINIB | 02 | N | 250031703 | BUSULPHAN |
| 250007288 | 250005131 | 1.77 | 0 | Curative (C) | 2013-04-03 | 2013-04-16 | RUXOLITINIB | 2 | N | 250031708 | PEG INTERFERON |
| 250007289 | 250005132 | 1.68 | 78 | null | 2014-01-01 | 2014-01-01 | RUXOLITINIB | null | N | 250031711 | RUXOLITINIB |
| 250007290 | 250005133 | 1.67 | null | Palliative (P) | 2016-04-21 | 2016-04-21 | LENALIDOMIDE | Y | N | 250031713 | RUXOLITINIB |
| 250007291 | 250005134 | null | 63.1 | Curative (C) | 2017-02-13 | 2017-02-14 | Rituximab | null | N | 250031715 | RUXOLITINIB |
| 250007294 | 250005136 | 0 | 83.6 | Palliative (P) | 2013-12-13 | 2013-12-13 | RUXOLITINIB | N | N | 250031719 | RUXOLITINIB |
| 250007295 | 250009707 | null | null | Palliative (P) | 2015-09-06 | 2016-05-22 | AML18 PILOT TRIAL | 02 | N | 250031720 | ABIRATERONE |
| 250007296 | 250009707 | 1.7 | 50 | Palliative (P) | 2014-07-21 | 2014-07-21 | Imatinib 400mg | null | N | 250031720 | RUXOLITINIB |
| 250007297 | 250012378 | 0 | 61.3 | Curative (C) | 2013-11-05 | 2013-11-05 | Azacitidine | N | N | 250031723 | BUSULPHAN |
| 250007298 | 250012378 | 1.67 | 60.6 | Palliative (P) | 2017-07-29 | 2017-08-09 | RUXOLITINIB | 2 | N | 250031723 | RUXOLITINIB |
| 250007299 | 250012378 | 0 | 0 | Palliative (P) | 2018-01-09 | 2018-01-09 | CHOP R - 21 days | N | N | 250031723 | BORTEZOMIB |
| 250007300 | 250005137 | null | null | null | 2014-07-17 | 2014-07-17 | Azacitidine | 2 | N | 250031735 | RUXOLITINIB |
| 250007301 | 250005138 | 1.7 | 110.6 | Adjuvant (A) | 2014-03-25 | 2014-03-25 | RUXOLITINIB | 1 | N | 250031736 | ANAGRELIDE |
| 250007303 | 250009708 | null | null | Palliative (P) | 2013-06-26 | 2013-07-07 | Busulfan Oral | 2 | N | 250031739 | RITUXIMAB |
| 250007304 | 250005140 | 1.89 | null | Not known (9) | 2014-07-20 | 2014-07-20 | Trial Unspecified | 1 | N | 250031746 | PEMETREXED |
| 250007305 | 250005140 | 1.74 | 52.5 | Adjuvant (A) | 2013-09-09 | 2013-09-10 | IMATINIB | N | N | 250031746 | INTERFERON |
| 250007306 | 250005140 | 1.8 | 84.3 | Palliative (P) | 2017-08-17 | 2017-08-17 | Busulfan Oral | N | N | 250031746 | RUXOLITINIB |
| 250007307 | 250005140 | 1.4 | 72 | Disease modification (D) | 2016-01-15 | 2016-02-03 | ANAGRELIDE | 02 | N | 250031746 | RUXOLITINIB |
| 250007308 | 250005141 | 1.69 | 121.4 | Disease modification (D) | 2017-01-09 | 2017-01-09 | Trial Unspecified | N | N | 250031753 | HCX |
| 250007309 | 250005142 | 1.72 | 83.2 | Adjuvant (A) | 2016-05-25 | 2016-06-06 | RUXOLITINIB | N | N | 250031757 | CHLORAMBUCIL |
| 250007310 | 250005142 | 0 | 0 | Disease modification (D) | 2014-11-30 | 2014-12-04 | Capecitabine + Mitomycin | 02 | N | 250031757 | AZACITIDINE |
| 250007311 | 250005143 | null | null | null | 2018-03-23 | 2018-03-30 | Rituximab | 02 | N | 250031762 | RUXOLITINIB |
| 250007312 | 250005144 | 0 | 64 | Adjuvant (A) | 2016-04-07 | 2016-06-08 | Azacitidine | N | N | 250031764 | CISPLATIN + FLUOROURACIL |